Indaptus Therapeutics Unveils Details On Mechanism Of Action Data That Demonstrates The Company's Decoy Platform Induces, Matures Or Activates Multiple Immune Cell Types Involved In Anti-tumor Responses, At AACR Research Annual Meeting
Indaptus Therapeutics Unveils Details On Mechanism Of Action Data That Demonstrates The Company's Decoy Platform Induces, Matures Or Activates Multiple Immune Cell Types Involved In Anti-tumor Responses, At AACR Research Annual Meeting
Indaptus Therapeutics在AACR研究年會上公佈了作用機制數據的詳細信息，這些數據表明該公司的誘餌平台可以誘導、成熟或激活參與抗腫瘤反應的多種免疫細胞類型
Indaptus Therapeutics Unveils Details On Mechanism Of Action Data That Demonstrates The Company's Decoy Platform Induces, Matures Or Activates Multiple Immune Cell Types Involved In Anti-tumor Responses, At AACR Research Annual Meeting
Indaptus Therapeutics在AACR研究年會上公佈了作用機制數據的詳細信息，這些數據表明該公司的誘餌平台可以誘導、成熟或激活參與抗腫瘤反應的多種免疫細胞類型
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。